Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases.

Romain Naud Julien BermudezNoémie ResseguierAna NievesBérengère ColteyNadine DufeuClarisse GautierYoussef TriguiMarc LaineBenjamin CoiffardMartine Reynaud-Gaubert

Published in: ERJ open research (2023)

Oral targeted pulmonary arterial hypertension therapies do not improve exercise capacity in patients with severe pulmonary hypertension associated with chronic lung disease, but could improve haemodynamic parameters.

Keyphrases

pulmonary arterial hypertension
pulmonary hypertension
pulmonary artery
cancer therapy
early onset
drug induced
high intensity
physical activity
resistance training
drug delivery
body composition
coronary artery